Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Elimination of Modifiable Risk Factors for Anticoagulant-Related Bleeding in Patients with Cancer Reduces the Probability of Bleeding

Kristen M. Sanfilippo, Yan Yan, Suhong Luo, Su-Hsin Chang, Martin William Schoen, Amber Afzal, Kenneth R. Carson, Brian F. Gage

Blood (2024) 144 (Supplement 1): 814.

https://doi.org/10.1182/blood-2024-206168

Published: 2024

Journal Articles

Type 2 Diabetes Mellitus Increases the Risk for Developing Monoclonal Gammopathy of Undetermined Significance in Asian Populations

Su-Hsin Chang, Mei Wang, Pin-Xiang Chen, Sylvia H Hsu, Ming-Che Hu, Chia-Cheng Wei

Blood (2024) 144 (Supplement 1): 6898.

https://doi.org/10.1182/blood-2024-211127

Published: 2024

Journal Articles

The Association between Rheumatological Diseases and Monoclonal Gammopathy of Undetermined Significance

Mahta Salehi, Nathan Logan, Mei Wang, Qingyuan Tan, Martin W Schoen, Su-Hsin Chang

Blood (2024) 144 (Supplement 1): 6897.

https://doi.org/10.1182/blood-2024-210655

Published: 2024

Journal Articles

The Association between Cumulative Excess Body Mass Index Exposure and Change in Monoclonal Protein Level in Veterans Diagnosed with Monoclonal Gammopathy of Undetermined Significance

Lawrence W Liu, Ekaterina Proskuriakova, Mei Wang, Murali Janakiram, Martin William Schoen, Kristen M. Sanfilippo, Theodore Thomas, Su-Hsin Chang

Blood (2024) 144 (Supplement 1): 6885.

https://doi.org/10.1182/blood-2024-206269

Published: 2024

Journal Articles

Machine Learning-Based Clinical and Laboratory Values Associated with Serum Protein Electrophoresis Testing in US Veterans

Byron Sigel, Qingyuan Tan, Mei Wang, Theodore Thomas, Kristen M. Sanfilippo, Daphne Friedman, Martin William Schoen, Su-Hsin Chang

Blood (2024) 144 (Supplement 1): 7859.

https://doi.org/10.1182/blood-2024-210974

Published: 2024

Journal Articles

Racial Differences in the Association of Glucagon-like Peptide 1 Agonist Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in US Veterans with Diabetes Mellitus

Nikhil Grandhi, Lawrence Liu, Mei Wang, Theodore Thomas, Akhil Kumar, Feng Gao, Kristen M. Sanfilippo, Graham Colditz, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 4772.

https://doi.org/10.1182/blood-2023-179135

Published: 2023

Journal Articles

Monoclonal Gammopathy of Undetermined Significance and Risk of Cardiovascular Disease in US Veterans

Lawrence Liu, Niharika Pant, Mei Wang, Nikhil Grandhi, Ekaterina Proskuriakova, Murali Janakiram, Theodore Thomas, Kristen M. Sanfilippo, Graham Colditz, Daphne R Friedman, Martin William Schoen, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 4773.

https://doi.org/10.1182/blood-2023-185155

Published: 2023

Journal Articles

Clinical and Laboratory Indications for Serum Protein Electrophoresis Testing in US Veterans: A Retrospective Cohort Study

Niharika Pant, Lawrence Liu, Mei Wang, Nikhil Grandhi, Theodore Thomas, Kristen M. Sanfilippo, Graham Colditz, Daphne R Friedman, Martin William Schoen, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 4778.

https://doi.org/10.1182/blood-2023-190735

Published: 2023

Journal Articles

Monoclonal Protein Concentration and Risk of Multiple Myeloma: Is 0.5 g/DL the New 1.5?

Mahta Salehi, Mei Wang, Kristen M. Sanfilippo, Theodore Thomas, Martin William Schoen, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 2040.

https://doi.org/10.1182/blood-2023-190852

Published: 2023

Journal Articles

Available Risk Scores Modestly Predict Hemorrhage in Patients with Atrial Fibrillation and Cance

Kristen M. Sanfilippo, Suhong Luo, Martin W. Schoen, Su-Hsin Chang, Brian F. Gage

Blood (2022) 140 (Supplement 1): 8528–8529.

https://doi.org/10.1182/blood-2022-168223

Published: 2022

Journal Articles

Racial Difference in Dynamic Markers for Progression of MGUS Using Machine Learning Approaches

Yaochi Yu, Mei Wang, Lawrence Liu, Theodore S. Thomas, Martin Schoen, Kristen M. Sanfilippo, Graham A Colditz, Jr-Shin Li, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 7830–7831.

https://doi.org/10.1182/blood-2022-167464

Published: 2022

Journal Articles

Racial Difference in Part D Enrollment and Survival Among Older Patients with Multiple Myeloma

Rong Wang, Natalia Neparidze, Xiaomei Ma, Graham A Colditz, Su-Hsin Chang, Shi-Yi Wang

Blood (2022) 140 (Supplement 1): 5270–5271.

https://doi.org/10.1182/blood-2022-164741

Published: 2022

Journal Articles

The Association of Agent Orange Exposure Duration with Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Progression: A Population-Based Study

Lawrence Liu, Mei Wang, Nikhil Grandhi, Mark A. Schroeder, Theodore S. Thomas, Akhil Kumar, Kristin Vargo, Feng Gao, Kristen M. Sanfilippo, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 4356–4357.

https://doi.org/10.1182/blood-2022-167305

Published: 2022

Journal Articles

The Association between Body Mass Index Trajectory and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Lawrence Liu, Nikhil Grandhi, Mei Wang, Theodore S. Thomas, Akhil Kumar, Kristin Vargo, Kristen M. Sanfilippo, Graham A Colditz, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 4283–4284.

https://doi.org/10.1182/blood-2022-167126

Published: 2022

Journal Articles

Association between SLGT2 Inhibitor Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Nikhil Grandhi, Lawrence Liu, Mei Wang, Theodore S. Thomas, Kristen M. Sanfilippo, Feng Gao, Graham A Colditz, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 10022–10023.

https://doi.org/10.1182/blood-2022-167846

Published: 2022

Journal Articles

Post-MGUS Diagnosis Serum M-Protein Velocity and the Risk of Progression of MGUS to Multiple Myeloma

Su-Hsin Chang, PhD, Jason H. Gumbel, Theodore S. Thomas, MD MPHS, Suhong Luo, MS, Kristen M. Sanfilippo, MD MPHS, Graham A Colditz, MD DrPH, Kenneth R. Carson, MD PhD

Blood (2017) 130 (Supplement 1): 4343.

https://doi.org/10.1182/blood.V130.Suppl_1.4343.4343

Published: 2017

Journal Articles

Is Body Mass Index Related to the Progression of Monoclonal Gammopathy of Unknown Significance to Multiple Myeloma?

Theodore Thomas, Su-Hsin Chang, PhD, M.S., Suhong Luo, MPH, Katiuscia O'Brian, Graham A Colditz, MD, Dr.PH., Kenneth R Carson, MD

Blood (2014) 124 (21): 2061.

https://doi.org/10.1182/blood.V124.21.2061.2061

Published: 2014

Journal Articles

Effect of Body Mass Index (BMI) At Diagnosis On Survival Patterns of Multiple Myeloma (MM) Patients in the Veterans Health Administration (VHA).

Kristen M. Sanfilippo, MD, Tracey Beason, Ph.D., MSPH, Su-Hsin Chang, Ph.D., M.S., Suhong Luo, MPH, Graham A Colditz, M.D., Dr.PH., Ravi Vij, MD, Michael H. Tomasson, MD, Arun Ganti, MPHS, Kenneth R. Carson, MD

Blood (2012) 120 (21): 3182.

https://doi.org/10.1182/blood.V120.21.3182.3182

Published: 2012

NARROW

Elimination of Modifiable Risk Factors for Anticoagulant-Related Bleeding in Patients with Cancer Reduces the Probability of Bleeding

Type 2 Diabetes Mellitus Increases the Risk for Developing Monoclonal Gammopathy of Undetermined Significance in Asian Populations

The Association between Rheumatological Diseases and Monoclonal Gammopathy of Undetermined Significance

The Association between Cumulative Excess Body Mass Index Exposure and Change in Monoclonal Protein Level in Veterans Diagnosed with Monoclonal Gammopathy of Undetermined Significance

Machine Learning-Based Clinical and Laboratory Values Associated with Serum Protein Electrophoresis Testing in US Veterans

Racial Differences in the Association of Glucagon-like Peptide 1 Agonist Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in US Veterans with Diabetes Mellitus

Monoclonal Gammopathy of Undetermined Significance and Risk of Cardiovascular Disease in US Veterans

Clinical and Laboratory Indications for Serum Protein Electrophoresis Testing in US Veterans: A Retrospective Cohort Study

Monoclonal Protein Concentration and Risk of Multiple Myeloma: Is 0.5 g/DL the New 1.5?

Available Risk Scores Modestly Predict Hemorrhage in Patients with Atrial Fibrillation and Cance

Racial Difference in Dynamic Markers for Progression of MGUS Using Machine Learning Approaches

Racial Difference in Part D Enrollment and Survival Among Older Patients with Multiple Myeloma

The Association of Agent Orange Exposure Duration with Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Progression: A Population-Based Study

The Association between Body Mass Index Trajectory and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Association between SLGT2 Inhibitor Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Post-MGUS Diagnosis Serum M-Protein Velocity and the Risk of Progression of MGUS to Multiple Myeloma

Is Body Mass Index Related to the Progression of Monoclonal Gammopathy of Unknown Significance to Multiple Myeloma?

Effect of Body Mass Index (BMI) At Diagnosis On Survival Patterns of Multiple Myeloma (MM) Patients in the Veterans Health Administration (VHA).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only